Stock · ZYDUSLIFE · Pharmaceuticals
ZYDUSLIFE share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for Zydus Lifesciences Limited, refreshed every end-of-day run. A systematic, data-only read on Zydus Lifesciences Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum. Refreshed from real price structure each run.
The verdict
BazaarBaazi reads ZYDUSLIFE as constructive with a Crack Score of 87/100 as of 9 Jun 2026.
BazaarBaaziSource & method
Price target: support and resistanceComputed 9 Jun 2026
Support and resistance for ZYDUSLIFE are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 9 Jun 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the ZYDUSLIFE chart, refreshed every end-of-day run.
The Crack Score, and how it is built87 / 100 · High conviction
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for ZYDUSLIFE, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on ZYDUSLIFE reads right now.
The futures and options read on ZYDUSLIFE leans to a call-side build. Strike-level positioning is read inside the latest show, against the printed spot. Single-stock F&O on ZYDUSLIFE is thinner than the index, so open-interest shifts read with more noise; the desk weights price structure over raw OI. This is a structural reading of positioning, not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving ZYDUSLIFE.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 9 Jun 2026. Why ZYDUSLIFE moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
Zydus Lifesciences Limited's most recent quarter, parsed straight from the official NSE filing. Every figure links back to its primary source.
Result Pulse
80 / 100Revenue
Rs 7,587 crNet profit
Rs 1,341 crEPS (quarter)
Rs 12.65| Growth | YoY | QoQ |
|---|---|---|
| Revenue | +16.2% | +10.5% |
| Net profit | +7.8% | +31.1% |
| Net margin | +17.7% | |
Figures are the Q4 FY26 result for ZYDUS LIFESCIENCES LIMITED, parsed straight from the official NSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the ZYDUSLIFE chart. Not a substitute for a registered research note.
| Ticker | ZYDUSLIFE |
|---|---|
| Full name | Zydus Lifesciences Limited |
| Sector | Pharmaceuticals |
| Index class | LARGE CAP |
| ISIN | NSE-ZYDUSLIFE |
| Market-cap band | ~1.1 lakh cr |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 9 Jun 2026 |
| Aliases tracked | ZYDUSLIFE |
Reference chartLevels in show
The daily frame the desk reads on ZYDUSLIFE.
FAQ8 reader questions · AEO-eligible
The line on ZYDUSLIFE, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the ZYDUSLIFE share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on ZYDUSLIFE. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 9 Jun 2026.
What is BazaarBaazi's Crack Score for ZYDUSLIFE?
The BazaarBaazi Crack Score for ZYDUSLIFE is 87 out of 100 as of 9 Jun 2026, a high conviction reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on ZYDUSLIFE?
As of 9 Jun 2026, BazaarBaazi reads ZYDUSLIFE positioning as a call-side build. This is a structural reading of the option chain, not a derivatives recommendation.
What sector is ZYDUSLIFE in and which peers does BazaarBaazi track?
ZYDUSLIFE sits in Pharmaceuticals (large cap), indicative market cap ~1.1 lakh cr, ISIN NSE-ZYDUSLIFE. The peers BazaarBaazi reads alongside it are Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited. A systematic, data-only read on Zydus Lifesciences Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum. Refreshed from real price structure each run.
How often is the ZYDUSLIFE view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on ZYDUSLIFE is bullish, published in Systematic Read on 9 Jun 2026.
What was ZYDUS LIFESCIENCES LIMITED's Q4 FY26 net profit?
ZYDUS LIFESCIENCES LIMITED reported a net profit of Rs 1,341 cr for Q4 FY26 (the quarter ended 31 March 2026). That is +7.8% year on year. The figure is from the company's official NSE filing.
What was ZYDUS LIFESCIENCES LIMITED's Q4 FY26 revenue?
ZYDUS LIFESCIENCES LIMITED reported revenue of Rs 7,587 cr for Q4 FY26. That is +16.2% year on year. The figure is from the company's official NSE filing.
How does BazaarBaazi rate ZYDUS LIFESCIENCES LIMITED's Q4 FY26 result?
BazaarBaazi gives ZYDUS LIFESCIENCES LIMITED's Q4 FY26 result a Result Pulse of 80 out of 100, with a verdict of Margin expansion. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
Related stock views
The names BazaarBaazi reads alongside ZYDUSLIFE, each a living view refreshed every end-of-day run.
Hub
All stock views
The full BazaarBaazi coverage universe, scored and dated.
Pharmaceuticals
SUNPHARMA
Sun Pharmaceutical Industries Limited
Pharmaceuticals
DRREDDY
Dr. Reddy's Laboratories Limited
Pharmaceuticals
CIPLA
Cipla Limited
Pharma APIs and CDMO
DIVISLAB
Divi's Laboratories Limited
Pharmaceuticals
TORNTPHARM
Torrent Pharmaceuticals Limited